Meta shares tumble despite earnings beating estimates

Meta shares sank on the release of Q3 earnings, despite the tech giant beating estimates, as investors fretted about rising AI-related costs.

Revenue for the period was $51.24 billion, an increase of 26% year-over-year and higher than the $49.41bn analysts had predicted.

Meta shares were down 8% in the US premarket.

However, the decline in shares was not a fair reflection of the group’s underlying progress on key metrics. Core measures, such as average price per ad and the number of users, all showed strength.

Unfortunately, higher revenues and better performance were masked by a one-off tax charge of $15bn, which led to an 83% drop in net income for the period.

There were also concerns around higher spending and costs. Costs and expenses rose 32% to an eyewatering $30bn as the firm ramped up spending on AI.

“Meta’s quarter highlighted a familiar tension: strong user engagement versus rising costs. The company’s platforms continue to see impressive activity, helped by AI-driven improvements, but investors focused on two negatives – lower growth for the next quarter and a sharp increase in spending plans,” said Matt Britzman, senior equity analyst, Hargreaves Lansdown.

“Zuckerberg is betting heavily on AI infrastructure, which means profits will likely come under pressure in the near term. He argues this is essential to secure a bigger long-term opportunity, but the trade-off is clear: higher costs now for uncertain future gains. For some, that’s a reasonable risk; for others, it’s a concern given how much control rests with one person.”

Shawbrook Group prices IPO middle of the range

Shawbrook Group has priced its initial public offering at 370p per share, the middle of the 350p – 390p range set out earlier in October.

The price gives the specialist lender a market capitalisation of approximately £1.92 billion.

The IPO comprises 13.5 million new shares raising £50 million in gross proceeds, alongside 80.5 million existing shares being sold by the bank’s sole shareholder, Marlin Bidco Limited.

The total offer size amounts to £348 million, representing 18.1 per cent of the company’s issued share capital.

Approximately £25 million of the offer was allocated to retail investors, who will receive 6.8 million shares through participating investment platforms and wealth managers.

Conditional dealings in Shawbrook shares commenced on the London Stock Exchange today under the ticker SHAW.

“The strong support we have received from investors across the UK, Europe and the US, reflects the strength of Shawbrook’s proposition and the business we have built. We are proud to be listing in London – our home market – a milestone that positions us well for the opportunities ahead,” said Marcelino Castrillo, Chief Executive Officer.

“We have built scale across diverse, attractive markets and, following significant investment under private ownership, are well placed to keep growing as we support UK businesses and households.

“As a listed company, we will continue to invest in our platform and people, deepen our presence in chosen markets and expand selectively where we see attractive demand. Our priorities are clear: keep supporting our customers and deliver sustainable, profitable growth and long-term value for all stakeholders.”

AIM movers: 80 Mile Greenland boost and Journeo’s New York order

1

Resources explorer 80 Mile (LON: 80M) says its US joint venture partner has announced that an independent report confirms the world-class potential of the Jameson Land Basin in eastern Greenland. This estimates more than 13 billion barrels (P10) of gross unrisked recoverable prospective oil resources. 80 Mile has a 30% post earn-in share. It has a free carry on the initial drilling planned for the second half of 2026. March GL is earning up to 70%. This follows yesterday’s announcement that 80 Mile has revised the terms of its acquisition of Hydrogen Valley, which operates a biofuel site in Italy. The share price increased 11.1% to 0.8p.

Artemis Resources (LON: ARV) assay results for the Titan East target at the Carlow resource. A down hole interval of 5 metres grading at 13.1g/t gold was identified from a 132 metre drill hole. This is in a previously unrecognised zone of mineralisation. The share price gained 10.7% to 0.415p.

AI analytics technology services provider Insig AI (LON: INSG) has won a contract with an international law firm. This is the first legal practice that Insig AI’s Generative Intelligence Engine has been sold to. The share price improved 7.41% to 29p.

Journeo (LON: JNEO) has received a $5m order from Outfront Media to supply platform displays systems for the Metropolitan Transportation Authority in New York. Deliveries will start in the second half of 2026. The share price rose 7.42% to 492.5p.

WH Ireland (LON: WHI) has received the final payment of £1.1m for the sale of the capital markets business to Zeus. This was the full amount deferred and was based on revenues in the 12 months since the disposal. The share price recovered 4.55% to 1.15p.

FALLERS

Shares in bars operator The Revel Collective (LON: TRC) continue to decline following last week’s news that it is conducting a strategic review, which includes a formal sales process. Net debt was £25.3m at the end of September 2025. Additional funding will be required to stay within banking limits. First quarter like-for-like revenues were 7.4% lower. The share price slipped a further 16.7% to 0.15p.

Guardian Metal Resources (LON: GMET) had cash of $1.87m at the end of June 2025. Subsequent fundraisings have increased the cash position to $14.7m. The share price declined 7.83% to 106p.

Unified marketplace for AI agents Sundae Bar (LON: SBAR) has raised £1m at 6p/share and a WAP retail offer could raise up to £100,000. The cash will accelerate the growth of the sundae_bar platform. The share price fell 6.9% to 6.75p.

FTSE 100 storms to record high on US/China trade deal hopes

The FTSE 100 soared to a fresh intraday record high on Wednesday as hopes of a US/China trade deal boosted sentiment.

London’s leading index was trading 0.5% to the good at the time of writing, touching highs above 9,750.

“A positive mood on Wall Street extended into European markets on Wednesday on increased hopes for a US-China trade deal,” said AJ Bell investment director Russ Mould.

“US indices closed at record levels, with sentiment also supported by reports Nvidia will announce new AI chip supply contracts with major South Korean operators like Samsung and Hyundai.

Last week, we published an article exploring whether Nvidia could hit $200 before it reports earnings in November. We explained that Nvidia’s achievement of this milestone depended on US/China trade talks and the outcome for Nvidia’s exports to China.

Trump’s overnight comments that he would discuss Nvidia’s ‘super-duper’ Blackwell chips with China at the upcoming talks were all the equity bulls needed to send Nvidia through $200 in the US pre-market on Wednesday and towards a $5 trillion valuation.

The FTSE 100 has missed out on several US tech-inspired rallies recently, but not so on Wednesday, with cyclical sectors enjoying the improved sentiment.

“The FTSE 100 built on its own all-time highs this morning, with miners doing a lot of the heavy lifting and positive corporate updates from Next and GSK also contributing,” Russ Mould said.

Next was the FTSE 100’s top riser, surging over 7%, after the retailer yet again defied the negative feeling around the UK to produce sales growth that beat expectations and drove an upgrade of full-year earnings.

“Next seems to have missed the memo on Britain’s slowdown,” said Mark Crouch, market analyst for eToro.

“The British retail giant has nudged up profit guidance for the fourth time in eight months, after third-quarter full-price sales rose an impressive 10.5%. While rivals have spent the year tripping over rising costs and cautious consumers, Next has managed to glide serenely through it all.

“Even more striking is the message behind the numbers. This is a retailer whose shares are up over 40% this year and whose leadership still finds room for a special dividend come January 2026.”

Glencore shares rose 6% after releasing Q3 production figures, which showed a 36% jump in copper production.

Fresnillo and Endeavour Mining were back among the gainers as gold prices rose above $4,000.

Housebuilders were at the bottom of the FTSE 100 leaderboard for the second day running.

The global equity rally will face several hurdles later today, when big tech reports in the US and the Fed releases its interest rate decision.

“A key test of investors’ optimism looks set to come later with the US Federal Reserve’s decision on interest rates and earnings reports from Alphabet, Meta and Microsoft.”

Bitcoin stablises near $113,000 with no clear catalyst for further gains

Bitcoin prices are consolidating recent gains that saw the cryptocurrency fail to attack recent highs around $125,000.

The outlook for Bitcoin looks increasingly hazy after a massive liquidation of leveraged cryptocurrencies left many traders licking their wounds and likley hesitant to take on as much risk as they did before the great unwind in September.

In addition, risk events aren’t having as much impact on Bitcoin as they did just a few weeks ago, leaving the coin without an obvious catalyst for the next phase of price action.

“Bitcoin stabilized near $113,000 today after two consecutive days of decline, attempting to find footing as short-term traders reassess the balance between fading leverage and improving sentiment in broader risk markets,” explained Samer Hasn, Senior Market Analyst at XS.com.

“This stabilization may offer a glimpse of recovery potential, yet it remains fragile and conditional on the persistence of supportive macro drivers. Fundamentally, the combination of improving broader stock market sentiment, renewed trade optimism between the United States and China, and recovering inflows into Bitcoin exchange-traded funds could help restore market confidence.

“However, the continued weakness in spot bitcoin accumulation and the still-elevated liquidation levels in futures markets suggest that any rebound might remain technical rather than structural.”

GSK lifts guidance after strong Q3

GSK reported third-quarter sales of £8.5 billion, up 8% at constant exchange rates, driven by strong performance across its Specialty Medicines, Vaccines and General Medicines divisions.

GSK shares rose over 3% on Wednesday, and investors will hope the strong sales momentum gives GSK a fighting chance of breaking out of its decade-long trading range that has capped the stock around 1,800p.

The pharmaceutical giant’s Specialty Medicines unit led growth with sales of £3.4 billion, up 16%. HIV treatments generated £1.9 billion in revenue, rising 12%, whilst Oncology sales surged 39% to £0.5 billion.

Vaccine sales reached £2.7 billion, with shingles vaccine Shingrix climbing 13% to £0.8 billion and respiratory vaccine Arexvy jumping 36% to £0.3 billion. General Medicines contributed £2.5 billion, with respiratory treatment Trelegy posting particularly strong growth of 25% to £0.7 billion.

Higher sales across most divisions helped core operating profit increase 11% to £3.0 billion, whilst core earnings per share rose 14% to 55.0 pence.

For the year to date, GSK generated £6.3 billion in operating cash flow and £1.2 billion in free cash flow during the quarter.

Such was the strength of sales in Q3 that GSK upgraded its full-year guidance, now expecting 2025 turnover growth of 6% to 7%, up from its previous guidance of 3% to 5%. Core operating profit growth is forecast at 9% to 11%, whilst core earnings per share growth is projected at 10% to 12%—both metrics raised from the prior 6% to 8% range.

“GSK has breezed past third quarter forecasts with beats at both the top and bottom line,” said Derren Nathan, head of equity research, Hargreaves Lansdown.

“Britain’s second largest pharmaceutical company’s vital signs are in excellent shape, with growth seen in all segments, as Dame Emma Walmsley passes the CEO baton to Luke Miels. The emerging cancer franchise saw the strongest growth at 39%. With new approvals for blood cancer treatment Blenrep and a recent deal adding a prostate cancer candidate to the research pipeline, the prognosis is promising. 

“Emma Walmsley’s left a parting gift for investors with the second upgrade of the year, with sales and profit guidance both moving into a new range. Full-year revenue is now expected to grow 6-7% with the underlying profit growth range moving from 6-8% to 9-11%. This is helped not just by the revenue uplift, but also a better product mix and improved efficiencies. The market remains to be convinced that GSK can meet its £40 billion sales target by 2031. The company’s certainly moving in the right direction but it’s now down to the new man at the helm to keep that momentum going.”

Next shares jump on raised profit guidance as weather helps boost sales

Next has upgraded its full-year profit guidance yet again after sales significantly outperformed expectations in the third quarter.

The fashion retailer reported full-price sales growth of 10.5% in the 13 weeks to 25 October, beating its own forecast by £76m.

Investors will be pleased to see that the strong performance has prompted the company to increase its fourth-quarter sales guidance from 4.5% to 7.0%.

“Next seems to have missed the memo on Britain’s slowdown,” said Mark Crouch, market analyst for eToro.

“The British retail giant has nudged up profit guidance for the fourth time in eight months, after third-quarter full-price sales rose an impressive 10.5%. While rivals have spent the year tripping over rising costs and cautious consumers, Next has managed to glide serenely through it all.”

Next shares were 5% higher at the time of writing as the stock continued its meteoric rise.

International sales proved the standout performer, surging 38.8% against last year. This far exceeded the 28.1% growth achieved in the first half and smashed the company’s guidance of 19.4%.

The company attributed its overseas success to two key factors. Next was able to spend 50% more on digital marketing than planned and achieved improved stock availability by consolidating its European warehousing operations with Zalando.

UK sales rose 5.4%, ahead of the 1.9% guidance but slower than the first half’s 7.6%. Management said they had underestimated the benefit of improved stock levels this year, after deliveries were delayed by disruptions in Bangladesh and global freight constraints last year.

“A double-digit rise in Q3 full-price sales and another profit upgrade show the group’s mix of disciplined inventory control and digital marketing is still working nicely,” said Chris Beauchamp, Chief Market Analyst UK at IG.

“Overseas growth was striking, with online sales up nearly 40%, suggesting its platform strategy has real international traction. The only worry is weakness in the UK as the domestic consumer cools, but even that looks well managed given Next’s track record of navigating downturns.”

Looking ahead, Next expects growth to ease – something it has warned of before, only to produce strong figures.

UK sales are forecast to slow to 4.1% in the fourth quarter as the exceptional first-half conditions normalise. Those earlier months benefited from favourable weather and competitor disruption.

Overseas growth is also expected to moderate to 24.3% in Q4 as the company cycles last year’s dramatic step-up. However, on a two-year basis, the momentum remains strong.

Next anticipates generating around £425m in surplus cash this year. It has already returned £131m through share buybacks but won’t purchase more shares at current prices, as those prices exceed its £121-per-share limit.

Instead, the retailer plans a special dividend of approximately £3.10 per share in January 2026, assuming no acquisitions materialise. The interim dividend of 87p per share will be paid on 5 January.

Total group sales guidance for the full year now stands at £6.87bn, up 8.7% on last year.

Alice & Bob partners with NVIDIA to accelerate fault-tolerant Quantum Computing

Quantum computing pioneer Alice & Bob has announced a collaboration with NVIDIA to integrate the chipmaker’s NVQLink architecture into its fault-tolerant quantum computing systems.

The partnership centres around NVQLink, NVIDIA’s open-source platform launched at GTC Washington this week that integrates GPUs into real-time quantum feedback loops, addressing a critical challenge in fault-tolerant quantum computing (FTQC).

NVQLink accelerates the development of logical qubits by enabling GPU computation alongside qubit decoding and calibration.

“In the near future, every NVIDIA GPU scientific supercomputer will be hybrid, tightly coupled with quantum processors to expand what is possible with computing,” said Jensen Huang, founder and CEO of NVIDIA.

“NVQLink is the Rosetta Stone connecting quantum and classical supercomputers — uniting them into a single, coherent system that marks the onset of the quantum-GPU computing era.”

The collaboration between Alice & Bob and NVIDIA builds on existing ties between the companies’ quantum software teams.

Products, including Alice & Bob’s high-performance GPU simulation tool Dynamiqs, were developed using the NVIDIA CUDA-Q platform.

Alice & Bob believe NVQLink will enable better FTQC solutions, bringing forward timelines for practical quantum computing applications.

“We are thrilled to see NVIDIA’s NVQLink addressing the layers of the FTQC stack we’ve long considered critical: logical orchestration, decoding, and live calibration,” said Jérémie Guillaud, VP of Firmware at Alice & Bob.

“This launch is a clear signal that fault-tolerant quantum computers, such as Alice & Bob’s QPUs, are about to reach industrial maturity.”

Based in Paris and Boston, Alice & Bob aims to create the first fault-tolerant quantum computer. Founded in 2020, the company has raised €130 million, employs over 150 staff, and has produced experimental results that surpass those of major technology firms.

Advised by Nobel Prize-winning researchers, Alice & Bob specialises in cat qubits, a technology it claims can reduce hardware requirements for large-scale quantum computers by up to 200 times compared with competing approaches.

FTSE 100 creeps higher as interest rate and trade talk hopes boost sentiment

The FTSE 100 tiptoed higher again on Tuesday and was set to reach another record high amid hopes of a US interest rate cut this week.

The gains, however, were meagre compared to a rally in the US overnight, which saw the S&P 500 close over 1.2% as tech shares soared. S&P 500 futures were flat going into the open.

London’s leading index was just 4 points higher at the time of writing at 9,658.

Investors globally had a spring in their step ahead of the Federal Reserve’s interest rate decision tomorrow and were also buoyed by progress in US-China trade relations.

“There are hopes that trade relations between Washington and Beijing can thaw when Presidents Donald Trump and Xi Jinping meet in South Korea later this week,” explained Derren Nathan, head of equity research, Hargreaves Lansdown.

“Trade deal progress has been difficult but successful discussions could pave the way for lighter export restrictions on advanced technology to China, as well as preventing proposed Chinese tariffs on rare-earth minerals that are essential for semiconductor fabrication.  Meanwhile, markets are all-but-certain of a quarter point cut by the Federal Reserve Bank tomorrow, and confidence in another similar cut in December is high.”

HSBC was among the risers in London after the bank announced revenues that beat expectations and increased income guidance. The positivity around HSBC’s underlying performance offset the hit from provisions relating to the Madoff Ponzi scheme, and shares rose more than 3%.

“HSBC’s latest results show solid progress toward its 2027 goals, proving the bank can still deliver despite legacy headwinds, with a 14% drop in pre-tax profit linked to the Madoff Ponzi scheme,” said Max Harper, Analyst at Third Bridge.

“Revenue beat consensus expectations by 5.9%, with strength across both net interest income and fees. The $1 billion upgrade to NII guidance should be well received, reflecting how the bank’s streamlined operating model is driving greater efficiency and returns.”

Airtel Africa was the FTSE 100’s top riser, surging more than 6%, after half-year revenue rose more than 25%. Operating profits jumped 35% as customer numbers rose sharply over the period.

The biggest detractors from the positivity in London were the housebuilders and UK retailers, which were showing signs of budget jitters.

AIM movers: Idox recommends bid and RWS profit at the bottom of guidance range

4

Idox (LON: IDOX) is recommending a 71.5p/share cash bid from Long Path Opportunities Fund. This values the public sector software and services company at £339.5m. Long Path has been a long-term shareholder, and it owns 12% of Idox. The belief is that as a private company Idox will be able to take a longer-term view and invest in new technology with the backing of Long Path. The share price jumped 25.2% to 70.6p.

Construction disputes and professional services provider Diales (LON: DIAL) expects a 2024-25 operating profit of at least £1.3m on slightly lower revenues of £42.6m, due to weaker Asia Pacific business. Pre-tax profit should also be £1.3m. Net cash was £3m at the end of September 2025. There is a strong pipeline of disputes business. The share price rebounded 14.7% to 19.5p.

Specialist cleaning services provider React Group (LON: REAT) says full year revenues were 21% ahead at around £25m, which includes an initial contribution from 24hr Aquaflow, which was acquired last October. Dowgate edged up its 2024-25 pre-tax profit from £2.1m to £2.2m. Strong fourth quarter trading meant that net debt was higher than expected at £5.2m. The share price recovered 13.2% to 51.5p, which is less than eight times estimated earnings, falling to less than six this year.  

Genedrive (LON: GDR) and its local distribution partner have signed a memorandum of understanding with the Kingdom of Saudi Arabia ministry of health to introduce the Genedrive MT-RNR1 ID Kit. This is a pilot that could extend to a national deal. The share price rose 10.2% to 0.535p.

FALLERS

ABCrescent Cooperatief U.A. has sold 8.22 million shares in Pulsar Helium Inc (LON: PLSR) at 38p/share. ABCrescent, which is associated with Pulsar Helium director Brice Laurent, still has a 4.81% stake plus 15.5 million warrants. Brie Laurent owns 17,570 shares. This follows the proposed acquisition of Hybrid Hydrogen, which owns mineral rights to 6,742 acres in Michigan’s Upper Peninsula, for $80,000 in shares. The share price fell back 14.8% to 38.5p.

Richmond Hill Resources (LON: RHR) has lost some of its premium to the 1p/share placing and offer price when the mining company moved from Aquis earlier in October. The share price had held at 1.4p since the move, but it has declined 14.3% to 1.2p.

Translation and software services provider RWS (LON: RWS) estimates that it made a pre-tax profit of £60m on broadly flat revenues on a constant currency basis in the year to September 2025. The profit was at the bottom of the guidance range. There was growth in AI, but regulated industries business declined. Net debt was £26m at the end of September 2025. Since then, the company has been restructured. The results will be published on 11 December. The share price slipped 10.5% to 84.2p.

Gunsynd (LON: GUN) says analysis of historical data has identified a new high-grade silver zinc lead target at the Bear Twit project in Canada. The area is called Enyo, and the anomaly is 1.5km long and 500 metres wide. Gunsynd owns 18 million shares in Richmond Hill Resources. The share price dipped 5.45% to 0.13p.